We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Philip Morris Earnings Preview: Smoke-Free Boosting Sales
Read MoreHide Full Article
Philip Morris International (PM - Free Report) , reports earnings on Thursday, February 9 before the market opens.
The tobacco and smoke-free nicotine alternative company continues to transition towards a smoke-free product line, evident from the shifting revenue streams.
Transition
Smoke-free products now make up more than 30% of total Philip Morris revenue. The firm’s acquisition of a nicotine pouch company, Swedish Match continues to help grow Philip Morris’ smoke-free segment.
The strategic move from Philip Morris has some interesting implications. Expectations for sales growth and margins are suffering in the short-term, but with changing consumer sentiment towards smoking, its likely that Philip Morris is setting itself up for long-term success. Furthermore, it makes the stock more compelling to investors, many of whom have opted out of investing in tobacco companies because of health concerns.
But while vapes and other smoke-free options appear to be an improvement in regards to consumers health, the long-term effect of the products are still somewhat unclear. Nonetheless, PM is committed to the plan.
Earnings Expectations
Philip Morris Q4 sales and earnings are expected to see a decline according to Zack’s estimates. Q4 sales are projected for a YoY decline of -8.2%, bringing sales down to $7.4 billion. Earnings are expected to come in at $1.29 per share, a -4.4% YoY decrease. However, PM still earns a Zacks Rank #1 (Strong Buy), because of its positive earnings revisions trend.
Analysts have mixed projections for current quarter earnings, with seven analysts revising higher over the last 60 days, and four revising lower over the same period. But next year’s earnings have analysts in unanimous agreement, with all eleven analysts revising expectations higher over the last 60 days. FY23 EPS has been revised from $5.60 per share to $5.96 over the last 90 days.
Image Source: Zacks Investment Research
Smoke-Free
Philip Morris’ business transformation hasn’t happened without some risks and challenges. Since Q4 FY21, margins have compressed by nearly 300 bps. However, PM is betting that this will pay off in the long-term as consumer habits change to prefer smokeless options.
Image Source: Zacks Investment Research
Philip Morris isn’t stopping with vapes either. At the end of 2022, PM became the sole owner of Swedish Match, the leading nicotine pouch product in the world. I know personally, I have seen an explosion in the use of their product Zyn. The acquisition cost PM $16 billion, and makes for a significant new additions to their product line.
An added benefit of PM’s acquisition of Swedish Match, is that it brings them back into the US market for the first time in 14 years. This move should keep PM’s US competitor Altria (MO - Free Report) on its toes.
Philip Morris has big plans as a smokeless company and states, “By 2025, our target is to increase that figure to at least 50 percent, with the ultimate goal of phasing out cigarettes completely. We also aim for USD 1 billion in annual net revenues to come from wellness and healthcare products.”
Valuation
Philip Morris currently trades at a one year forward P/E of 16.9x, a premium to the industry average, and just above it’s 5-year median of 15.2x. With the ongoing transition the company is going through it is quite impressive that it can maintain a premium valuation. That may signal investors giving PM a vote of confidence.
Image Source: Zacks Investment Research
PM is not a high-flying growth stock, but it is definitely a steady earner. The stock also has a very appealing 5% dividend yield.
Image Source: Zacks Investment Research
Conclusion
If you are an investor willing to stomach an allocation to a tobacco company, Philip Morris may well be a great addition to your portfolio. PM is actively shifting its business to be well positioned for the future, has a long history of success and offers the stability of a generous dividend yield.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Philip Morris Earnings Preview: Smoke-Free Boosting Sales
Philip Morris International (PM - Free Report) , reports earnings on Thursday, February 9 before the market opens.
The tobacco and smoke-free nicotine alternative company continues to transition towards a smoke-free product line, evident from the shifting revenue streams.
Transition
Smoke-free products now make up more than 30% of total Philip Morris revenue. The firm’s acquisition of a nicotine pouch company, Swedish Match continues to help grow Philip Morris’ smoke-free segment.
The strategic move from Philip Morris has some interesting implications. Expectations for sales growth and margins are suffering in the short-term, but with changing consumer sentiment towards smoking, its likely that Philip Morris is setting itself up for long-term success. Furthermore, it makes the stock more compelling to investors, many of whom have opted out of investing in tobacco companies because of health concerns.
But while vapes and other smoke-free options appear to be an improvement in regards to consumers health, the long-term effect of the products are still somewhat unclear. Nonetheless, PM is committed to the plan.
Earnings Expectations
Philip Morris Q4 sales and earnings are expected to see a decline according to Zack’s estimates. Q4 sales are projected for a YoY decline of -8.2%, bringing sales down to $7.4 billion. Earnings are expected to come in at $1.29 per share, a -4.4% YoY decrease. However, PM still earns a Zacks Rank #1 (Strong Buy), because of its positive earnings revisions trend.
Analysts have mixed projections for current quarter earnings, with seven analysts revising higher over the last 60 days, and four revising lower over the same period. But next year’s earnings have analysts in unanimous agreement, with all eleven analysts revising expectations higher over the last 60 days. FY23 EPS has been revised from $5.60 per share to $5.96 over the last 90 days.
Image Source: Zacks Investment Research
Smoke-Free
Philip Morris’ business transformation hasn’t happened without some risks and challenges. Since Q4 FY21, margins have compressed by nearly 300 bps. However, PM is betting that this will pay off in the long-term as consumer habits change to prefer smokeless options.
Image Source: Zacks Investment Research
Philip Morris isn’t stopping with vapes either. At the end of 2022, PM became the sole owner of Swedish Match, the leading nicotine pouch product in the world. I know personally, I have seen an explosion in the use of their product Zyn. The acquisition cost PM $16 billion, and makes for a significant new additions to their product line.
An added benefit of PM’s acquisition of Swedish Match, is that it brings them back into the US market for the first time in 14 years. This move should keep PM’s US competitor Altria (MO - Free Report) on its toes.
Philip Morris has big plans as a smokeless company and states, “By 2025, our target is to increase that figure to at least 50 percent, with the ultimate goal of phasing out cigarettes completely. We also aim for USD 1 billion in annual net revenues to come from wellness and healthcare products.”
Valuation
Philip Morris currently trades at a one year forward P/E of 16.9x, a premium to the industry average, and just above it’s 5-year median of 15.2x. With the ongoing transition the company is going through it is quite impressive that it can maintain a premium valuation. That may signal investors giving PM a vote of confidence.
Image Source: Zacks Investment Research
PM is not a high-flying growth stock, but it is definitely a steady earner. The stock also has a very appealing 5% dividend yield.
Image Source: Zacks Investment Research
Conclusion
If you are an investor willing to stomach an allocation to a tobacco company, Philip Morris may well be a great addition to your portfolio. PM is actively shifting its business to be well positioned for the future, has a long history of success and offers the stability of a generous dividend yield.